Paper42007653
Ocular Transmission of Red and Violet Light: Insights into Light-Based Myopia Therapies.
Priscilla JJ and 4 others. Transl Vis Sci Technol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Ocular Transmission of Red and Violet Light: Insights into Light-Based Myopia Therapies. Papers, record 42007653. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007653
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myopia | Major topic |
| Light | Major topic |
| Animals | |
| Red Light | |
| Swine | |
| Sclera | |
| Blue Light | |
| Retina | |
| Cornea | |
| Choroid | |
| Retinal Pigment Epithelium | |
| Lens, Crystalline |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34981548 | Low-intensity, long-wavelength red light slows the progression of myopia in children: an Eastern China-based cohort. | Ophthalmic Physiol Opt | 2022 | https://conductscience.org/library/papers/34981548 | PubMed |
| 2 | 33575355 | Orthokeratology and Low-Intensity Laser Therapy for Slowing the Progression of Myopia in Children. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/33575355 | PubMed |
| 3 | 36054314 | Sustained and rebound effect of repeated low-level red-light therapy on myopia control: A 2-year post-trial follow-up study. | Clin Exp Ophthalmol | 2022 | https://conductscience.org/library/papers/36054314 | PubMed |
| 4 | 38099371 | A meta-analysis of randomized controlled trials evaluating the effectiveness and safety of the repeated low-level red light therapy in slowing the progression of myopia in children and adolescents. | Indian J Ophthalmol | 2024 | https://conductscience.org/library/papers/38099371 | PubMed |
| 5 | 29981345 | Narrow-band, long-wavelength lighting promotes hyperopia and retards vision-induced myopia in infant rhesus monkeys. | Exp Eye Res | 2018 | https://conductscience.org/library/papers/29981345 | PubMed |
| 6 | 35404516 | Effects of mild- and moderate-intensity illumination on short-term axial length and choroidal thickness changes in young adults. | Ophthalmic Physiol Opt | 2022 | https://conductscience.org/library/papers/35404516 | PubMed |
| 7 | 40905918 | Radiometric and safety assessment of a 'low-level red-light' myopia control device. | Ophthalmic Physiol Opt | 2025 | https://conductscience.org/library/papers/40905918 | PubMed |
| 8 | 38244655 | Effects of repeated low-level red-light therapy on macular retinal thickness and microvascular system in children with myopia. | Photodiagnosis Photodyn Ther | 2024 | https://conductscience.org/library/papers/38244655 | PubMed |
| 9 | 19925789 | Ultraviolet radiation transmittance of the mouse eye and its individual media components. | Exp Eye Res | 2010 | https://conductscience.org/library/papers/19925789 | PubMed |
| 10 | 28801261 | Long-wavelength (red) light produces hyperopia in juvenile and adolescent tree shrews. | Vision Res | 2017 | https://conductscience.org/library/papers/28801261 | PubMed |
| 11 | 21287191 | The parameters of the porcine eyeball. | Graefes Arch Clin Exp Ophthalmol | 2011 | https://conductscience.org/library/papers/21287191 | PubMed |
| 12 | 37786442 | Repeated Low-Level Red-Light Therapy for Controlling Onset and Progression of Myopia-a Review. | Int J Med Sci | 2023 | https://conductscience.org/library/papers/37786442 | PubMed |
| 13 | 26303444 | Current and predicted demographics of high myopia and an update of its associated pathological changes. | Ophthalmic Physiol Opt | 2015 | https://conductscience.org/library/papers/26303444 | PubMed |
| 14 | 15739174 | Cellular effects of low power laser therapy can be mediated by nitric oxide. | Lasers Surg Med | 2005 | https://conductscience.org/library/papers/15739174 | PubMed |
| 15 | 37074407 | Photobiomodulation at 660 nm promotes collagen synthesis via downregulation of HIF-1α expression without photodamage in human scleral fibroblasts in vitro in a hypoxic environment. | Graefes Arch Clin Exp Ophthalmol | 2023 | https://conductscience.org/library/papers/37074407 | PubMed |
| 16 | 36294321 | Short-Term Exposure to Violet Light Emitted from Eyeglass Frames in Myopic Children: A Randomized Pilot Clinical Trial. | J Clin Med | 2022 | https://conductscience.org/library/papers/36294321 | PubMed |
| 17 | 18588438 | Low-level laser therapy improves vision in patients with age-related macular degeneration. | Photomed Laser Surg | 2008 | https://conductscience.org/library/papers/18588438 | PubMed |
| 18 | 39167378 | Light Therapy for Myopia Prevention and Control: A Systematic Review on Effectiveness, Safety, and Implementation. | Transl Vis Sci Technol | 2024 | https://conductscience.org/library/papers/39167378 | PubMed |
| 19 | 24222304 | Progressive myopia or hyperopia can be induced in chicks and reversed by manipulation of the chromaticity of ambient light. | Invest Ophthalmol Vis Sci | 2013 | https://conductscience.org/library/papers/24222304 | PubMed |
| 20 | 38563650 | Red light therapy for myopia: Merits, risks and questions. | Ophthalmic Physiol Opt | 2024 | https://conductscience.org/library/papers/38563650 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42007653
GET https://conductscience.org/api/papers/v1/42007653/references?page=2